ClinVar Miner

Submissions for variant NM_000337.6(SGCD):c.848A>G (p.Gln283Arg)

gnomAD frequency: 0.00019  dbSNP: rs397516338
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000172107 SCV000051050 uncertain significance not provided 2013-06-24 criteria provided, single submitter research
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036266 SCV000059918 likely benign not specified 2014-11-25 criteria provided, single submitter clinical testing p.Gln283Arg in exon 9 of SGCD: This variant is not expected to have clinical sig nificance because it has been identified in 0.6% (57/8734) of East Asian chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs397516338).
Illumina Laboratory Services, Illumina RCV000404763 SCV000455500 likely benign Limb-girdle muscular dystrophy, recessive 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000365095 SCV000455502 likely benign Qualitative or quantitative defects of delta-sarcoglycan 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Invitae RCV001084187 SCV000638182 likely benign Autosomal recessive limb-girdle muscular dystrophy type 2F 2024-01-29 criteria provided, single submitter clinical testing
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000584814 SCV000692523 likely benign Hypertrophic cardiomyopathy 1 2017-03-16 criteria provided, single submitter research The SGCD Gln283Arg variant is present at high frequency in the Exome Aggregation Consortium dataset and is particularly common in the East Asian population; allele frequency=0.006379 (MAF= 0.0004690, http://exac.broadinstitute.org/). We identified SGCD Gln283Arg in 1 HCM proband with no family history of HCM or SCD. Computational tools PolyPhen-2 and MutationTaster predict the amino acid substitution to be "probably damaging" and "disease-causing" respectively, however SIFT predicts this variant to be "tolerated". In summary, based on the current literature, our limited understanding of the role of SGCD in HCM, and an allele frequency higher than expected for HCM, we classify SGCD Gln283Arg as "likely benign".
Genetics and Genomics Program, Sidra Medicine RCV001293129 SCV001434119 likely benign Primary dilated cardiomyopathy criteria provided, single submitter research
GeneDx RCV000172107 SCV001818906 likely benign not provided 2019-10-28 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32344918, 26720722, 23861362, 27707468)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000036266 SCV002555818 likely benign not specified 2022-06-10 criteria provided, single submitter clinical testing Variant summary: SGCD c.848A>G (p.Gln283Arg) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00056 in 248152 control chromosomes (gnomAD), predominantly at a frequency of 0.0076 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 11 fold of the estimated maximal expected allele frequency for a pathogenic variant in SGCD causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.00072), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. To our knowledge, no occurrence of c.848A>G in individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive has been reported. One publication has found that the variant protein interacts with other SGC proteins in an identical manner as wild-type, although there is reduced cell surface expression of the complete SGC complex (Chen_2015). Five ClinVar submitters have assessed the variant since 2014: all five classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.
Revvity Omics, Revvity RCV000172107 SCV004237244 uncertain significance not provided 2023-03-15 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003944896 SCV004763148 likely benign SGCD-related disorder 2020-12-17 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.